NOCD Announces Plans for National Expansion of Intensive Outpatient Therapy
NOCD, a virtual provider for OCD, announced plans to expand its virtual intensive outpatient program for people with severe OCD nationwide.
NOCD, a virtual provider for OCD, announced plans to expand its virtual intensive outpatient program for people with severe OCD nationwide.
NOCD launched a new parent brand, Noto, and acquired PTSD provider Rebound Health to expand its virtual, specialty therapy model beyond OCD into other complex mental health conditions.
Talkiatry and NOCD are teaming up to improve care for patients with obsessive-compulsive disorder. Talkiatry specializes in medication management, while NOCD specializes in Exposure and Response Prevention therapy.
The four companies are Alma, Headway, NOCD and Ophelia. Alma and Headway will help Empire expand its mental health provider network, while NOCD and Ophelia will address specific conditions: obsessive-compulsive disorder and opioid use disorder, respectively.
NOCD recently closed a $33 million funding round, led by F-Prime Capital. The startup plans to reach more people with OCD to offer exposure and response prevention therapy, a type of therapy that is considered an effective treatment for OCD, but can be difficult to find.
NOCD, a digital health company that connects users to therapists for OCD and self-help tools, has seen the number of people using its platform double since the Covid-19 pandemic started.